PMEF
BSX icon

Point72 Middle East FZE’s Boston Scientific BSX Stock Holding History

Point72 Middle East FZE’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-384,098
Closed -$20.1M – 1485
2023
Q2 		$20.8M Buy
384,098
+383,037
+36,102% +$20M 0.58% 20
2023
Q1 		$53.1K Sell
1,061
-5,630
-84% -$265K ﹤0.01% 1262
2022
Q4 		$310K Buy
+6,691
New +$290K 0.01% 890

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Middle East FZE's BSX Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 384,098 shares — an estimated $20.1M sold.

Point72 Middle East FZE first reported a position in BSX in Q4 2022 and held it in 3 quarters. The position peaked at $20.8M in Q2 2023. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 384,098 Boston Scientific shares in Q3 2023, an estimated $20.1M.
  • Point72 Middle East FZE first reported a position in Boston Scientific in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's Boston Scientific position peaked at $20.8M in Q2 2023.
  • 1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.